Rosiglitazone For Type 2 Diabetes Does Not Increase Risk Of Cardiovascular Disease Or Death But Increases Heart Failure And Fractures In Women

June 9, 2009

Using rosiglitazone (Avandia) in combination with standard diabetes treatments (metformin or a sulfonylurea) to lower blood glucose in type 2 diabetics does not increase the risk of cardiovascular disease or death. However, the study confirms that using rosiglitazone more than doubles the risks of heart failure, and also increases the risk of fractures, mainly in women. The findings of the RECORD study are published in an Article Online First and in an upcoming edition of Read the rest of this entry »


Researchers Develop An Intelligent Chip Which Regulates Diabetes

June 7, 2009

Scientists of the Electronic Technology group of the University of Seville (US), led by Professor José Manuel Quero, have completed the first phase of Mireia, a research project financed by the Plan Nacional del Ministerio de Ciencia e Innovación (National Plan of the Spanish Science and Innovation Ministry), whose aim is to develop an intelligent chip to regulate diabetes in any kind of patients suffering this disease.

With this research, the idea is to extract the interstitial liquid with micro needles that are 200 microns long (the double than a hair’s thickness). This painless process is carried out with sensors and micro fluidics and patients are informed every now and again in their mobiles of their level of glucose.
Read the rest of this entry »


Researchers Develop An Intelligent Chip Which Regulates Diabetes

June 7, 2009

Scientists of the Electronic Technology group of the University of Seville (US), led by Professor José Manuel Quero, have completed the first phase of Mireia, a research project financed by the Plan Nacional del Ministerio de Ciencia e Innovación (National Plan of the Spanish Science and Innovation Ministry), whose aim is to develop an intelligent chip to regulate diabetes in any kind of patients suffering this disease.

With this research, the idea is to extract the interstitial liquid with micro needles that are 200 microns long (the double than a hair’s thickness). This painless process is carried out with sensors and micro fluidics and patients are informed every now and again in their mobiles of their level of glucose.
Read the rest of this entry »


Combination Therapy For Type 2 Diabetes With Rosiglitazone (RECORD Study) Shows No Increase Of Cardiovascular Disease Or Death

June 6, 2009

The results of the RECORD study are reported in an article published Online First and in a future edition of The Lancet. The findings are presented at the same time at the American Diabetes Association (ADA) meeting in New Orleans, USA. They indicate that the use of rosiglitazone (Avandia) together with regular diabetes treatments (metformin or a sulfonylurea) to reduce blood glucose in type 2 diabetics does not raise the risk of cardiovascular disease or death. On the other hand, the research establishes that using rosiglitazone multiplies by more than two the risk of heart failure, and increases the risk of fracture, mostly in women.
Read the rest of this entry »


Combination Therapy For Type 2 Diabetes With Rosiglitazone (RECORD Study) Shows No Increase Of Cardiovascular Disease Or Death

June 6, 2009

The results of the RECORD study are reported in an article published Online First and in a future edition of The Lancet. The findings are presented at the same time at the American Diabetes Association (ADA) meeting in New Orleans, USA. They indicate that the use of rosiglitazone (Avandia) together with regular diabetes treatments (metformin or a sulfonylurea) to reduce blood glucose in type 2 diabetics does not raise the risk of cardiovascular disease or death. On the other hand, the research establishes that using rosiglitazone multiplies by more than two the risk of heart failure, and increases the risk of fracture, mostly in women.
Read the rest of this entry »


Physician / Preventive Medicine Expert Explains How To Reverse Obesity And Diabetes Naturally

May 28, 2009

Irving A. Cohen, MD, MPH, will be at Book Expo America 2009, Booth 5065, May 29-31, to discuss his new book “Dr. Cohen’s Guide to the New Hippocratic Diet™: How to Really Lose Weight and Beat the Obesity Epidemic” It teaches dieters how to lose weight easily and naturally despite having failed before.

In his book, Dr. Cohen explains how three decades ago the Federal government tried to “fix” the problem of overweight adults by recommending low-fat diets for all Americans. They were wrong. As a result, four times as many Americans are overweight. Because most Americans believe that bad advice, they gain weight as they try to diet. The government blocks efforts to help those who are overweight or who may suffer from Type 2 Diabetes, unless they conform to that misguided government policy.
Read the rest of this entry »


Reducing Heart Attack Risk In Diabetes

May 25, 2009

People with diabetes who maintain intensive, low blood sugar levels are significantly less likely to suffer heart attacks and coronary heart disease, new research published in The Lancet has shown.

By undertaking a meta-analysis which pooled information from five large trials, researchers at the University of Cambridge were for the first time able to provide reliable evidence linking intensive blood sugar level (or glucose) control with fewer heart attacks.
Read the rest of this entry »